Sana Biotechnology Inc vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while YieldMax Universe Fund of Option Income ETFs trades at $7.7. The key difference: Sana Biotechnology Inc is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| SANA | YMAX | |
|---|---|---|
Market Cap | $873.84M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $5.92 | $14.00 |
52-Week Low | $2.68 | $7.51 |
Enterprise Value | $848.03M | — |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →